(Q31168638)

29 June 2017

1 reference

title

From randomized trials to registry studies: translating data into clinical information (English)

1 reference

29 June 2017

5

Thoralf M Sundt

1 reference

29 June 2017

2

Bernard J Gersh

1 reference

29 June 2017

Morgan L Brown

1

1 reference

29 June 2017

David R Holmes

series ordinal

3

1 reference

29 June 2017

Kent R Bailey

series ordinal

4

1 reference

29 June 2017

publication date

5 August 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

29 June 2017

published in

1 reference

29 June 2017

volume

5

1 reference

29 June 2017

issue

10

1 reference

29 June 2017

page(s)

613-620

1 reference

Surrogate end points in clinical trials: are we being misled?

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Long-term outcomes of coronary-artery bypass grafting versus stent implantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

External Validity of Clinical Trials in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Pexelizumab and the APEX AMI trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Use and misuse of surrogate outcomes in arrhythmia trials.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Patients with malignant or potentially malignant ventricular arrhythmias: opportunities and limitations of drug therapy in prevention of sudden death

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

The cardiac arrhythmia suppression trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Composite outcomes in randomized trials: greater precision but with greater uncertainty?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

How to review a paper

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1307

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1307

1 reference

Dimensions Publication ID

29 June 2017

1009211368

0 references

1 reference